UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients

World journal of gastroenterology : WJG, 2013-12, Vol.19 (48), p.9156-9173

2013

Volltextzugriff (PDF)

Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients

Annals of transplantation, 2019-11, Vol.24, p.594-604

2019

Volltextzugriff (PDF)

Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial

Annals of transplantation, 2019-05, Vol.24, p.268-272

2019

Volltextzugriff (PDF)

Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis

Current opinion in rheumatology, 2007-05, Vol.19 (3), p.238-245

2007

Volltextzugriff (PDF)

Simultaneous Determination of Tacrolimus and Cyclosporine A in Whole Blood by Ultrafast LC-MS/MS

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1872, p.111

2019

Volltextzugriff (PDF)

Self-Emulsifying Drug Delivery System for Enhancing Bioavailability and Lymphatic Delivery of Tacrolimus

Journal of nanoscience and nanotechnology, 2015-02, Vol.15 (2), p.1831

2015

Volltextzugriff (PDF)

Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Annals of transplantation, 2017-09, Vol.22, p.575

2017

Volltextzugriff (PDF)

Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience

Annals of transplantation, 2017-11, Vol.22, p.707-718

2017

Volltextzugriff (PDF)

Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients

Annals of transplantation, 2016-02, Vol.21, p.105

2016

Volltextzugriff (PDF)

The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study

Annals of transplantation, 2014-07, Vol.19, p.337

2014

Volltextzugriff (PDF)

Tacrolimus-induced nephrotoxicity and genetic variability: a review

Annals of transplantation, 2012-01, Vol.17 (2), p.111-121

2012

Volltextzugriff (PDF)

Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms

Annals of transplantation, 2016-08, Vol.21, p.491

2016

Volltextzugriff (PDF)

Correlation of blood concentration of tacrolimus with serum cystatin C in renal transplant recipients and effect of tacrolimus on glucose and lipid metabolism

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2017-06, Vol.37 (6), p.817

2017

Volltextzugriff (PDF)

Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study

Annals of transplantation, 2014-01, Vol.19, p.32

2014

Volltextzugriff (PDF)

Tacrolimus concentration/dose ratio as a therapeutic drug monitoring strategy: the influence of gender and comedication

Vojnosanitetski pregled, 2015-09, Vol.72 (9), p.813-822

2015

Volltextzugriff (PDF)

TACROLIMUS DRUG LEVEL AND RESPONSE TO TREATMENT IN IDIOPATHIC CHILDHOOD STEROID RESISTANT NEPHROTIC SYNDROME

Journal of Ayub Medical College, Abbottabad, 2015-10, Vol.27 (4), p.784-787

2015

Volltextzugriff (PDF)

Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients

Annals of transplantation, 2011, Vol.16 (4), p.55-62

2011

Volltextzugriff (PDF)

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

Annals of transplantation, 2008, Vol.13 (3), p.11

Kuypers, Dirk R

2008

Volltextzugriff (PDF)

Polymorphisms in CYP3A53 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients

Annals of transplantation, 2011-01, Vol.16 (1), p.54

2011

Volltextzugriff (PDF)

Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients

Clinical transplants, 2014, p.209

2014

Volltextzugriff (PDF)

Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients

Annals of transplantation, 2013-07, Vol.18, p.349

2013

Volltextzugriff (PDF)

The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients

Medical science monitor, 2008-05, Vol.14 (5), p.CR251-CR254

2008

Volltextzugriff (PDF)

Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study

International journal of medical sciences, 2020-01, Vol.17 (7), p.859-864

2020

Volltextzugriff (PDF)

Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation

Rinshō ketsueki, 2012-04, Vol.53 (4), p.469

2012

Volltextzugriff (PDF)

Association of CYP3A5 and MDR1 genetic polymorphisms with the blood concentration of tacrolimus in Chinese liver and renal transplant recipients

Sichuan da xue xue bao. Journal of Sichuan University. Yi xue ban, 2013-07, Vol.44 (4), p.573-577

2013

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(70)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(79)
Tacrolimus - Pharmacokinetics
(74)
Immunosuppressive Agents - Pharmacokinetics
(65)
Science & Technology
(59)
Tacrolimus
(59)
Life Sciences & Biomedicine
(57)
Male
(48)
Female
(44)
Tacrolimus - Administration & Dosage
(39)
Adult
(37)
Immunosuppressive Agents - Administration & Dosage
(32)
Pharmacokinetics
(30)
Middle Aged
(29)
Transplantation
(27)
Tacrolimus - Therapeutic Use
(26)
Immunosuppressive Agents - Therapeutic Use
(23)
Kidney Transplantation
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Tacrolimus - Blood
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients

Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients

Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial

Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis

Simultaneous Determination of Tacrolimus and Cyclosporine A in Whole Blood by Ultrafast LC-MS/MS

Self-Emulsifying Drug Delivery System for Enhancing Bioavailability and Lymphatic Delivery of Tacrolimus

Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience

Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients

The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study

Tacrolimus-induced nephrotoxicity and genetic variability: a review

Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms

Correlation of blood concentration of tacrolimus with serum cystatin C in renal transplant recipients and effect of tacrolimus on glucose and lipid metabolism

Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study

Tacrolimus concentration/dose ratio as a therapeutic drug monitoring strategy: the influence of gender and comedication

TACROLIMUS DRUG LEVEL AND RESPONSE TO TREATMENT IN IDIOPATHIC CHILDHOOD STEROID RESISTANT NEPHROTIC SYNDROME

Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

Polymorphisms in CYP3A53 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients

Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients

Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients

The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients

Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study

Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation

Association of CYP3A5 and MDR1 genetic polymorphisms with the blood concentration of tacrolimus in Chinese liver and renal transplant recipients

Aktive Filter

Suchergebnisse filtern